Inventor profile of:

Ralph Stefan

City:

Ebenweiler

Country:

Germany

Published Applications:

17

Last publication date:

2024-07-11

Top Assignees for applications by Ralph Stefan

The entities that hold a legal rights for patent applications filed by inventor Stefan Ralph:

Recent patent applications by Stefan Ralph

Ralph Stefan from Ebenweiler, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-07-11
US20240226419A1
Human necessities

TRAY FOR RECEIVING A PLURALITY OF MEDICAL HOLLOW BODIES

#2 | 2017-05-18
US20170137453A1
Chemistry; metallurgy

Solid state forms of sofosbuvir

#3 | 2017-03-16
US20170071869A1
Human necessities

TRANSMUCOSAL DELIVERY OF LAQUINIMOD BY ORAL PATCHES

#4 | 2016-07-07
US20160193276A1
Human necessities

TRANSMUCOSAL DELIVERY OF GLATIRAMER ACETATE

#5 | 2016-02-11
US20160038435A1
Human necessities

TRANSDERMAL FORMULATIONS OF LAQUINIMOD

#6 | 2016-01-28
US20160022661A1
Human necessities

Dosage Form Comprising Crizotinib

#7 | 2015-11-19
US20150328277A1
Human necessities

ORAL TRANSMUCOSAL DELIVERY OF GLATIRAMER ACETATE

#8 | 2015-09-03
US20150246043A1
Human necessities

ORAL DOSAGE FORMS FOR MODIFIED RELEASE COMPRISING RUXOLITINIB

#9 | 2015-04-23
US20150111909A1
Human necessities

DOSAGE FORM COMPRISING NON-CRYSTALLINE LOPINAVIR AND CRYSTALLINE RITONAVIR

#10 | 2014-12-04
US20140357860A1
Chemistry; metallurgy

SALT OF IVABRADINE WITH ADIPIC ACID

#11 | 2014-10-30
US20140319720A1
Human necessities

PHARMACEUTICAL COMPOSITIONS COMPRISING RIVAROXABAN

#12 | 2013-08-29
US20130224294A1
Human necessities

DRY PROCESSING OF ATAZANAVIR

#13 | 2013-05-09
US20130116239A1
Human necessities

IVABRADINE-CONTAINING PHARMACEUTICAL COMPOSITION WITH MODIFIED RELEASE

#14 | 2012-09-13
US20120231076A1
Human necessities

PHARMACEUTICAL COMPOSITIONS COMPRISING RIVAROXABAN

#15 | 2012-08-09
US20120202820A1
Human necessities

PHARMACEUTICAL COMPOSITION HAVING THE ACTIVE SUBSTANCES METFORMIN AND SITAGLIPTIN OR VILDAGLIPTIN

#16 | 2012-08-02
US20120195966A1
Human necessities

ORAL DOSAGE FORM FOR MODIFIED RELEASE COMPRISING A JAK3 INHIBITOR

#17 | 2012-08-02
US20120195933A1
Human necessities

PHARMACEUTICAL COMPOSITIONS COMPRISING TASOCITINIB

InventorID:

236263 ⎘